David Shaw’s Vera Therapeutics VERA Stock Holding History

David Shaw’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.2M	Buy	74,509 +69,009	+1,255%	+$2.57M	﹤0.01%	2787
2026 Q1	$221K	Buy	+5,500	New	+$237K	﹤0.01%	4170
2025 Q3	–	Sell	-15,154	Closed	-$357K	–	4951
2025 Q2	$357K	Buy	+15,154	New	+$341K	﹤0.01%	3787
2025 Q1	–	Sell	-74,476	Closed	-$3.15M	–	4785
2024 Q4	$3.15M	Sell	74,476 -55,990	-43%	-$2.48M	﹤0.01%	2360
2024 Q3	$5.77M	Sell	130,466 -240,219	-65%	-$9.12M	0.01%	1827
2024 Q2	$13.4M	Sell	370,685 -230,351	-38%	-$9.14M	0.01%	1148
2024 Q1	$25.9M	Buy	601,036 +390,997	+186%	+$13.9M	0.02%	785
2023 Q4	$3.23M	Buy	210,039 +51,853	+33%	+$659K	﹤0.01%	2281
2023 Q3	$2.17M	Buy	+158,186	New	+$2.71M	﹤0.01%	2500

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

David Shaw's VERA Position: Q2 2026 in Review

David Shaw increased its Vera Therapeutics (VERA) stake by 1,255% in Q2 2026, buying an estimated $2.57M and bringing the position to 74,509 shares worth $3.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2787.

David Shaw first reported a position in VERA in Q3 2023 and has held it in 9 quarters since. The position peaked at $25.9M in Q1 2024. 218 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

David Shaw held 74,509 shares of Vera Therapeutics worth $3.2M as of Q2 2026.
David Shaw bought 69,009 Vera Therapeutics shares in Q2 2026, an estimated $2.57M.
Vera Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2787 holding.
David Shaw first reported a position in Vera Therapeutics in Q3 2023 and has held it in 9 quarters since.
David Shaw's Vera Therapeutics position peaked at $25.9M in Q1 2024.
218 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.